PL2247749T3 - Kowalencyjnie połączona termostabilna kinaza do walidacji procesu dekontaminacji - Google Patents
Kowalencyjnie połączona termostabilna kinaza do walidacji procesu dekontaminacjiInfo
- Publication number
- PL2247749T3 PL2247749T3 PL09712816T PL09712816T PL2247749T3 PL 2247749 T3 PL2247749 T3 PL 2247749T3 PL 09712816 T PL09712816 T PL 09712816T PL 09712816 T PL09712816 T PL 09712816T PL 2247749 T3 PL2247749 T3 PL 2247749T3
- Authority
- PL
- Poland
- Prior art keywords
- covalently linked
- decontamination process
- process validation
- thermostable kinase
- linked thermostable
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 238000005202 decontamination Methods 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 238000010200 validation analysis Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0803068.6A GB0803068D0 (en) | 2008-02-20 | 2008-02-20 | Cross-linked biological indicator |
| EP09712816A EP2247749B1 (en) | 2008-02-20 | 2009-02-18 | Covalently linked thermostable kinase for decontamination process validation |
| PCT/GB2009/050158 WO2009104013A1 (en) | 2008-02-20 | 2009-02-18 | Covalently linked thermostable kinase for decontamination process validation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2247749T3 true PL2247749T3 (pl) | 2013-05-31 |
Family
ID=39271974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09712816T PL2247749T3 (pl) | 2008-02-20 | 2009-02-18 | Kowalencyjnie połączona termostabilna kinaza do walidacji procesu dekontaminacji |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9416396B2 (pl) |
| EP (1) | EP2247749B1 (pl) |
| JP (1) | JP5597552B2 (pl) |
| CN (1) | CN102016065B (pl) |
| AU (1) | AU2009216579B2 (pl) |
| CA (1) | CA2713421C (pl) |
| ES (1) | ES2398018T3 (pl) |
| GB (1) | GB0803068D0 (pl) |
| PL (1) | PL2247749T3 (pl) |
| WO (1) | WO2009104013A1 (pl) |
| ZA (1) | ZA201005194B (pl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0406427D0 (en) * | 2004-03-22 | 2004-04-21 | Health Prot Agency | Biological indicator |
| EP1772522A1 (en) * | 2005-10-04 | 2007-04-11 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Control of preservation by biomarkers |
| GB0803068D0 (en) | 2008-02-20 | 2008-03-26 | Health Prot Agency | Cross-linked biological indicator |
| US10466245B2 (en) | 2008-02-20 | 2019-11-05 | The Secretary Of State For Health | Covalently linked thermostable kinase for decontamination process validation |
| WO2010068754A2 (en) | 2008-12-10 | 2010-06-17 | Paka Pulmonary Pharmaceuticals, Inc. | Methods and compositions for delivery of medicaments to the lungs |
| GB0900151D0 (en) * | 2009-01-07 | 2009-02-11 | Health Prot Agency | rapid bioluminescence detection system |
| GB201115911D0 (en) * | 2011-09-14 | 2011-10-26 | Health Prot Agency | Thermostable assay reagents |
| US20140272946A1 (en) * | 2013-03-15 | 2014-09-18 | Src, Inc. | Methods and Systems For DNA-Based Detection And Reporting |
| US9632087B2 (en) * | 2013-09-10 | 2017-04-25 | MockV Solutions | Methods for evaluating viral clearance from a biopharmaceutical solution employing mock viral particles |
| CA2937755A1 (en) * | 2014-01-24 | 2015-07-30 | University Of Wyoming Research Corporation D/B/A Western Research Institute | Volatile hydrocarbon separation and analysis apparatus |
| US10302614B2 (en) | 2014-05-06 | 2019-05-28 | Safetraces, Inc. | DNA based bar code for improved food traceability |
| US10962512B2 (en) * | 2015-08-03 | 2021-03-30 | Safetraces, Inc. | Pathogen surrogates based on encapsulated tagged DNA for verification of sanitation and wash water systems for fresh produce |
| JP7328763B2 (ja) * | 2017-02-09 | 2023-08-17 | キッコーマン株式会社 | 生体関連サンプル及び生体関連器具の清浄度測定キット及び方法 |
| US10926264B2 (en) | 2018-01-10 | 2021-02-23 | Safetraces, Inc. | Dispensing system for applying DNA taggants used in combinations to tag articles |
| US10556032B2 (en) | 2018-04-25 | 2020-02-11 | Safetraces, Inc. | Sanitation monitoring system using pathogen surrogates and surrogate tracking |
| US11853832B2 (en) | 2018-08-28 | 2023-12-26 | Safetraces, Inc. | Product tracking and rating system using DNA tags |
| US11200383B2 (en) | 2018-08-28 | 2021-12-14 | Safetraces, Inc. | Product tracking and rating system using DNA tags |
| CN113260387B (zh) | 2018-12-28 | 2024-01-30 | 爱思帕全球制造有限公司 | 处理指示器、其制造方法及其使用方法 |
| US12258638B2 (en) | 2020-04-16 | 2025-03-25 | Safetraces, Inc. | Airborne pathogen simulants and mobility testing |
| EP4202055A1 (de) | 2021-12-21 | 2023-06-28 | Bayer Aktiengesellschaft | Enzymindikatoren für die prozesskontrolle von sterilisationsprozessen |
| CN114592023B (zh) * | 2022-03-31 | 2023-03-24 | 杭州优玛达生物科技有限公司 | 一种细胞裂解自组装多肽复合物、自组装方法、自组装多肽制剂及应用 |
| US20250122487A1 (en) * | 2023-10-12 | 2025-04-17 | Codexis, Inc. | Engineered acetate kinase variants |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI901810A7 (fi) * | 1989-04-13 | 1990-10-14 | Vascular Laboratory Inc | Puhtaan pro-urokinaasin plasminogeeniaktivaattorikompleksi, joka on sidottu ihmisen seerumialbumiiniin disulfidisillan välityksellä |
| AU707191B2 (en) | 1995-12-28 | 1999-07-08 | Fujirebio Inc. | Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said protein |
| JP3360557B2 (ja) * | 1995-12-28 | 2002-12-24 | 富士レビオ株式会社 | 融合ｄｎａ配列、融合蛋白質及び該蛋白質を発現させる方法 |
| US6075184A (en) * | 1996-03-26 | 2000-06-13 | University Of Hawaii | Purified proteins, recombinant DNA sequences and processes for producing caffeine free beverages |
| JPH10259200A (ja) * | 1997-03-17 | 1998-09-29 | Fujirebio Inc | アデニレートキナーゼを認識するモノクローナル抗体及び該モノクローナル抗体を産生するハイブリドーマ |
| GB9902659D0 (en) | 1999-02-05 | 1999-03-31 | Microbiological Res Authority | Assay with reduced background |
| GB9922554D0 (en) | 1999-09-23 | 1999-11-24 | Microbiological Res Authority | Inhibition of secretion from non-neuronal cells |
| US7838008B2 (en) | 1999-12-07 | 2010-11-23 | Allergan, Inc. | Methods for treating diverse cancers |
| CA2402520A1 (en) * | 2000-03-13 | 2001-09-20 | Kenneth Beckman | Biocidal methods and compositions |
| WO2002094743A2 (de) | 2001-05-19 | 2002-11-28 | Siemens Axiva Gmbh & Co. Kg | Verfahren und vorrichtung zur durchführung von radikalischen gasphasenreaktionen |
| WO2004076634A2 (en) | 2003-02-24 | 2004-09-10 | Ira Sanders | Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease |
| GB0321344D0 (en) | 2003-09-11 | 2003-10-15 | Health Prot Agency | Re-targeted toxin conjugates |
| GB0406427D0 (en) * | 2004-03-22 | 2004-04-21 | Health Prot Agency | Biological indicator |
| US7514088B2 (en) | 2005-03-15 | 2009-04-07 | Allergan, Inc. | Multivalent Clostridial toxin derivatives and methods of their use |
| AU2005279741B2 (en) | 2004-09-01 | 2011-10-06 | Allergan, Inc. | Degradable clostridial toxins |
| GB0426397D0 (en) | 2004-12-01 | 2005-01-05 | Health Prot Agency | Fusion proteins |
| EP1863524A1 (en) | 2005-03-03 | 2007-12-12 | Universite Catholique De Louvain | Methods and compositions for the treatment of cancer |
| JP2008535486A (ja) | 2005-03-15 | 2008-09-04 | アラーガン、インコーポレイテッド | クロストリジウム毒素標的細胞に対する改変された標的能力を有する修飾クロストリジウム毒素 |
| EP2505592A1 (en) | 2006-07-11 | 2012-10-03 | Allergan, Inc. | Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity |
| GB0803068D0 (en) | 2008-02-20 | 2008-03-26 | Health Prot Agency | Cross-linked biological indicator |
| BRPI0915888E2 (pt) | 2008-06-12 | 2020-09-01 | Syntaxin Ltd | polipetídeo, seu método de ativação, sequência de ácido nucléico codificando o mesmo e seu uso |
| ES2732205T3 (es) | 2008-06-12 | 2019-11-21 | Ipsen Bioinnovation Ltd | Proteínas de fusión para uso en el tratamiento del cáncer |
-
2008
- 2008-02-20 GB GBGB0803068.6A patent/GB0803068D0/en not_active Ceased
-
2009
- 2009-02-18 JP JP2010547256A patent/JP5597552B2/ja active Active
- 2009-02-18 CN CN200980113883.4A patent/CN102016065B/zh active Active
- 2009-02-18 EP EP09712816A patent/EP2247749B1/en active Active
- 2009-02-18 AU AU2009216579A patent/AU2009216579B2/en active Active
- 2009-02-18 WO PCT/GB2009/050158 patent/WO2009104013A1/en not_active Ceased
- 2009-02-18 PL PL09712816T patent/PL2247749T3/pl unknown
- 2009-02-18 US US12/918,628 patent/US9416396B2/en active Active
- 2009-02-18 ES ES09712816T patent/ES2398018T3/es active Active
- 2009-02-18 CA CA2713421A patent/CA2713421C/en active Active
-
2010
- 2010-07-21 ZA ZA2010/05194A patent/ZA201005194B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102016065B (zh) | 2016-03-23 |
| AU2009216579A2 (en) | 2010-09-23 |
| WO2009104013A1 (en) | 2009-08-27 |
| US9416396B2 (en) | 2016-08-16 |
| CA2713421C (en) | 2016-11-01 |
| CN102016065A (zh) | 2011-04-13 |
| ZA201005194B (en) | 2011-06-29 |
| CA2713421A1 (en) | 2009-08-27 |
| AU2009216579A1 (en) | 2009-08-27 |
| EP2247749B1 (en) | 2012-12-26 |
| JP5597552B2 (ja) | 2014-10-01 |
| GB0803068D0 (en) | 2008-03-26 |
| EP2247749A1 (en) | 2010-11-10 |
| JP2011512151A (ja) | 2011-04-21 |
| AU2009216579B2 (en) | 2014-03-13 |
| ES2398018T3 (es) | 2013-03-13 |
| US20110177539A1 (en) | 2011-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201005194B (en) | Covalently linked thermostable kinase for decontamination process validation | |
| IL257418A (en) | Methods for treating addiction | |
| ZA201101307B (en) | Improved integrated chemical process | |
| IL198851A0 (en) | Methods for treating hypercholesterolemia | |
| GB0806422D0 (en) | Process | |
| GB0806419D0 (en) | Process | |
| EP2282826A4 (en) | PROCESS FOR TREATMENT OF ODOR | |
| GB0803669D0 (en) | Process | |
| GB0720891D0 (en) | Chemical process | |
| GB0801580D0 (en) | Process | |
| GB0801209D0 (en) | Process | |
| EP2328900A4 (en) | PROCESS FOR PREPARING MORPHINAN-6 alpha-OLS | |
| IL184342A0 (en) | Process for preparing ??-amino-??-hydroxycarboxamides | |
| GB0800875D0 (en) | Process | |
| GB0811851D0 (en) | Process | |
| IL210539A0 (en) | Process for treating polytmers containing residual catalyst | |
| GB0719218D0 (en) | Process tank | |
| ZA200907695B (en) | Process for preparing dorzolam ide | |
| GB0803960D0 (en) | Process | |
| ZA201104208B (en) | Process for resolving zopiclone | |
| GB0812423D0 (en) | Process for treating aqueous effluent | |
| GB0808357D0 (en) | Process | |
| GB0814784D0 (en) | Chemical process | |
| EP2375896A4 (en) | CHEMICAL PROCESS | |
| GB0808359D0 (en) | Process |